Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2021-12-31 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 90% confidence The document text is very short (726 characters) and appears to be a formal letter or notice addressed to stock exchanges (NSE and BSE) with company identification details and listing information. There is no substantive financial data, no detailed report content, no management discussion, or any other detailed disclosure. It does not contain financial statements or detailed report content. It is not an announcement of voting results, nor a call transcript or earnings release. Given the brevity and nature, it is likely a Regulatory Filing (RNS) as a general announcement or compliance document without detailed report content.
2021-12-31 English
Credit Rating
Regulatory Filings Classification · 90% confidence The document text is extremely short (598 characters) and contains only header information related to stock exchanges and listing departments, with no substantive content or financial data. There is no indication of a report, announcement, or detailed filing. It appears to be a regulatory or administrative notice without any detailed report or announcement. Given the lack of content and the nature of the text, the best fit is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-12-25 English
Investor Presentation
Regulatory Filings
2021-12-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for omitted pictures and no substantive text content. The true document length is only 147 characters, indicating it is extremely short and contains no financial data, report content, or announcements. Given the lack of any report or announcement text, this document cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2021-12-20 English
Outcome of Board Meeting
Regulatory Filings
2021-12-16 English
Updates
Regulatory Filings
2021-12-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.